The LEMD3 gene helps control signals that guide how bone and skin tissue grow and repair. This gene plays an important role in keeping those signals balanced, so if it does not work properly, some people develop extra dense spots or streaks in bone and small skin bumps or patches. Variants in the LEMD3 gene are linked to conditions such as osteopoikilosis, Buschke-Ollendorff syndrome, and some cases of melorheostosis. Effects can vary widely, even within the same family.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or direct activities in the body. Some genes provide the instructions for producing proteins, which do much of the work inside cells. Others mainly regulate when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in the LearnHub.
Overview
LEMD3Gene function
What if the gene works
The LEMD3 gene makes a protein in the membrane around the cell nucleus. It helps control signals that tell cells when to grow and change, especially in bone and skin.
Risk
What if the gene does not work
Variants in the LEMD3 gene can cause dense bone spots and small connective tissue skin bumps, often grouped as Buschke-Ollendorff syndrome. Effects may range from none to pain or stiffness, and more disruptive variants can bring broader findings.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the LEMD3 gene is currently established. Research is exploring how the LEMD3 gene affects cell signals that help control bone and skin growth, but this has not yet changed routine drug choices.
Conditions associated with LEMD3
Gene function
What if the gene works
The LEMD3 gene helps your cells keep growth signals in balance, especially signals involved in bone and connective tissue. Its protein is positioned at the edge of the nucleus, where it can filter some of the messages that tell cells when to grow, build, or remodel tissue. When this system works normally, everyday cell communication stays more controlled.
The LEMD3 gene helps tone down growth messages from the TGF-β and BMP pathways, which are cell signaling systems that guide tissue building and repair. This keeps cells from overreacting to routine signals and supports balanced development.
Its protein sits in the inner membrane around the nucleus, the cell’s control center. From this position, it acts as a docking point for signal messengers and helps set how strongly certain growth instructions reach the DNA.
By moderating these signals, the LEMD3 gene supports normal bone shaping and steady connective tissue maintenance. This reflects the LEMD3 gene’s function in bone growth and tissue remodeling across life.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene functions more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Different LEMD3 gene variants can weaken, shorten, or stop production of the MAN1 protein, changing how cells handle growth signals involved in bone and connective tissue. In practice, how LEMD3 gene variants affect protein function depends on the change: some smaller variants may partly disrupt folding or key interactions, while more disruptive variants often lead to an unstable or missing protein. When loss of function is greater, bone and skin findings may be broader or appear earlier in some families.
How variants are linked to conditions
Pathogenic variants in the LEMD3 gene cause Buschke-Ollendorff syndrome, a condition linked to small firm skin bumps and characteristic bone spots on X-rays called osteopoikilosis. Some people with a LEMD3 gene variant have osteopoikilosis without obvious skin changes, and genetic testing can confirm the diagnosis. LEMD3-related melorheostosis has also been reported, but Buschke-Ollendorff syndrome and osteopoikilosis are the best-established associations.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead reflect normal human variation. For many genes, a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In contrast, a single well understood variant in a particular gene can sometimes be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LEMD3, risk is mainly shaped by whether you carry a disease-causing change in the gene, often because it runs in the family. There is not yet broadly confirmed evidence that lifestyle, diet, or everyday exposures clearly increase or reduce the chance of developing LEMD3-related bone or skin changes.
Inheritance of LEMD3 variants
Variants in the LEMD3 gene are usually inherited in an autosomal dominant pattern. This means a person with a disease-causing LEMD3 variant has a 50% chance of passing it to each child. In families asking how LEMD3 variants are inherited, the key point is that one altered copy can be enough to cause LEMD3-related conditions such as Buschke-Ollendorff syndrome or osteopoikilosis. Men and women can inherit and pass on these variants equally.
What does my LEMD3 result mean for my family?
A disease-causing change in the LEMD3 gene is usually passed in a dominant pattern, so close relatives such as a parent, brother, sister, or child may also carry the same change. In families with a confirmed LEMD3-related condition, relatives can have very different signs, from no obvious symptoms to skin bumps or areas of extra bone spotting seen on imaging. This means the result may be relevant to several family members, not just one person.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for LEMD3 variants usually uses a blood or saliva sample. A lab reads the DNA in the LEMD3 gene to look for changes and reports whether a variant was found, not found, or has unclear meaning.
When should I consider getting a genetic test?
Consider testing for changes in the LEMD3 gene if you or a close relative has the pattern of many small bone spots seen on X-rays, especially along with firm skin bumps or patches. Testing can help confirm an inherited condition linked to LEMD3 and clarify whether it may run in the family.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Over time, the way the body works is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may be more likely to cause side effects, because the body can absorb, break down, transport, or respond to a drug differently. These differences are common and are one reason medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support treatment decisions that are both better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the LEMD3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines are chosen or how people respond to treatment, so questions about side effects, new symptoms, or changes to your medicines are best discussed with your doctor.
History
Features now linked to the LEMD3 gene were described long before the gene itself was identified. In the early 20th century, physicians reported Buschke-Ollendorff syndrome and osteopoikilosis as inherited conditions that often ran in families. Building on this early work, scientists mapped the shared genetic cause and, in 2004, connected pathogenic variants in the LEMD3 gene with both conditions. That finding helped show that skin and bone changes seen together could come from one inherited cause rather than separate problems. Later studies also linked some cases of melorheostosis to changes involving the same gene, which added another chapter to its clinical history.